Related Experiment Video

Updated: Aug 10, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

Formation of protease-resistant prion protein in cell-free systems

B Caughey1

  • 1Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, MT 59840, USA.

Current Issues in Molecular Biology
|July 27, 2001
PubMed

Insights

The abnormal prion protein (PrP-res) directly converts normal host prion protein (PrP-sen) into a pathogenic form. This cell-free reaction explains prion disease barriers and strains at a molecular level.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Transmissible spongiform encephalopathies (TSEs), or prion diseases, involve the conversion of normal host prion protein (PrP-sen) into a pathogenic, protease-resistant form (PrP-res).
  • The precise molecular mechanisms driving this conversion and the origins of TSE-specific barriers and strains remain incompletely understood.

Purpose of the Study:

  • To investigate the direct role of PrP-res in inducing the conversion of PrP-sen.
  • To elucidate the molecular basis for TSE species barriers, polymorphism barriers, and strains.

Main Methods:

  • Utilizing cell-free reaction systems with purified PrP-sen and PrP-res.
  • Observing the conversion reaction in TSE-infected brain slices.

Main Results:

  • PrP-res directly induces the conversion of PrP-sen in cell-free reactions.
  • The conversion reaction exhibits high specificity, mirroring TSE species and strain characteristics.
  • The mechanism involves PrP-sen binding to polymeric PrP-res, followed by conformational changes and incorporation into the polymer.

Conclusions:

  • The PrP-res-induced conversion of PrP-sen provides a molecular explanation for prion disease specificity.
  • This mechanism underlies TSE species barriers, polymorphism barriers, and the existence of distinct prion strains.

More Related Videos

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay11:41

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay

Published on: March 10, 2015

High-throughput Screening for Protein-based Inheritance in S. cerevisiae08:12

High-throughput Screening for Protein-based Inheritance in S. cerevisiae

Published on: August 8, 2017

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...